Kypho-scoliotic ehlers-danlos syndrome Q79.6

Author: Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 25.09.2022

Dieser Artikel auf Deutsch

Synonym(s)

Ehlers-Danlos syndrome type VI; kEDS-FKBP14; kEDS-PLODI; Kyphoscoliotic Ehlers-Danlos syndrome; Kypho-skoliotic EDS

Definition
This section has been translated automatically.

Ehlers-Danlos Syndrome (EDS) is a heterogeneous group of hereditary connective tissue diseases whose main clinical features are overstretchability of the skin and hyperreflexia of the joints. Depending on the type of disease and the underlying gene mutations, vessels, muscles, ligaments, tendons and internal organs are also affected (Brady A et al. 2017).

So far, 19 gene mutations are known to trigger EDS. The various mutations lead to changes in the structure, production or processing of collagen or of proteins that interact with collagen. The frequency of occurrence in the population is assumed to be 1:5,000 to 1:10,000, making EDS a rare disease (orphan disease).

The very rare kypho-scoliotic Ehlers Danlos syndrome (kEDS, formerly Ehlers Danlos type VI) is an autosomal recessive inherited, rare variant of Ehlers Danlos syndrome (Brady A et al. 2017)

Etiopathogenesis
This section has been translated automatically.

Mutations can be detected in the kEDS-PLOD1 gene, which is located on chromosome 1p36.22 and codes for lysyl hydroxylase PLODI. Less frequent are mutations in the FKBP 14 gene, which is located on chromosome 7p14.3 (Shin YL et al. 2020).

Clinical features
This section has been translated automatically.

The clinical symptoms are classified according to major and minor symptoms (Brinckmann J 2018)

Major symptoms are:

  • Neuromuscular symptoms: Congenital muscular hypotension
  • Skeletal system: Congenital or early kyphoscoliosis (progressive or non-progressive), severe generalized hypermobility of the joints with dislocations or subluxations (shoulders, knees, hips)

Minor symptoms:

  • Skin: Hyperelasticity, hematoma formation with risk of subcutaneous hematoma and hemorrhages
  • Vascular system: Rupture or aneurysm of medium-sized arteries
  • Skeletal system: clubfoot, breast deformity, Marfanoid habitus,. osteopenia/osteoporosis,

Other: Hernias, eyes: blue sclerae, ametropia,

Diagnosis
This section has been translated automatically.

Determination of the genetic defect; analysis of the cross-links of collagen in urine

Major criterion congenital muscle hypertension +

Major symptoms congenital or early onset kyphoscoliosis + either

  • Major symptom severe generalized hypermobility of the joints

or

  • three other minor symptoms

Note(s)
This section has been translated automatically.

Note: The diagnosis of PLOD1-related kyphoscoliotic Ehlers-Danlos syndrome is made in a subject with typical clinical findings and biallelic pathogenic (or likely pathogenic) PLOD1 variants identified by molecular genetic testing. If only one or no pathogenic variant is identified, testing for a markedly elevated urinary deoxypyridinoline to pyridinoline crosslink ratio measured by high-performance liquid chromatography (HPLC) may be required to confirm the diagnosis (Yeowell HN et al (2022).

Literature
This section has been translated automatically.

  1. Ayoub S et al (2020) Clinical features, molecular results, and management of 12 individuals with the rare arthrochalasia Ehlers-Danlos syndrome. Am J Med Genet A doi: 10.1002/ajmg.a.61523.
  2. Bowen et al.(2017): Ehlers-Danlos syndrome, classical type. American Journal of Medical Genetics 175C:17-39.
  3. Brady A et al (2017): Ehlers-Danlos syndromes, rarer types. In: Ehlers-Danlos Society. American Journal of Medical Genetics 175C:70-115.
  4. Brinckmann J (2018) Hereditary connective tissue disorders. In. Plewig et al (eds) Braun-Falco`s Dermatology, Venereology and Allergology, Springer Reference Medicine pp 883-890.
  5. Byers PH et al (2019): Diagnosis, natural history, and management in vascular Ehlers-Danlos syndrome. Am Journal of Medical Genetics 175C:40-47.
  6. Chopra P et al.(2017): Pain management in the Ehlers-Danlos syndromes. American J
  7. Guarnieri V et al (2019) Cardiac valvular Ehlers-Danlos syndrome is a well-defined condition due to recessive null variants in COL1A2. Am J Med Genet A 179:846-851.
  8. Malfait F et al (2006) Total absence of the alpha2(I) chain of collagen type I causes a rare form of Ehlers-Danlos syndrome with hypermobility and propensity to cardiac valvular problems.J Med Genet 43:e36.
  9. Malfait F et al (2004) The natural history, including orofacial features of three patients with Ehlers-Danlos syndrome, dermatosparaxis type (EDS type VIIC). Am J Med Genet A 131:18-28.
  10. Melis D et al (2012) Cardiac valve disease: an unreported feature in Ehlers Danlos syndrome arthrocalasia type? Ital J Pediatr 38:65.
  11. Micale L et al (2019) Novel TNXB Variants in Two Italian Patients with Classical-Like Ehlers-Danlos Syndrome. Genes (Basel) 10: doi: 10.3390/genes10120967.
  12. Shin YL et al (2020) Rare Cases of PLOD1-Related Kyphoscoliotic Ehlers-Danlos Syndrome in a Korean Family Identified by Next Generation Sequencing. J Korean Med Sci 35:e96.
  13. Yeowell HN et al (2022) PLOD1-Related Kyphoscoliotic Ehlers-Danlos Syndrome. 2000 Feb 2 [updated 2018 Oct 18]. In: Adam MP, Everman DB, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2022.

Incoming links (1)

PLOD1 Gene;

Disclaimer

Please ask your physician for a reliable diagnosis. This website is only meant as a reference.

Authors

Last updated on: 25.09.2022